Latest Period
Q2 2026
Security Snapshot
BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG) Institutional Ownership
CUSIP: 10919W405
13F Institutional Holders and Ownership History from Q3 2023 to Q2 2026
Institutions Reporting
100
Shares (Excl. Options)
9,311,244
Price
$70.20
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- DRUG on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 9,311,244
- Total 13F value
- $653,781,549
- Portfolio coverage rank
- 0%
- Share change
- +58,108
- Value change
- +$2,881,153
- Number of holders
- 100
- Shares outstanding
- 9,814,613
- SEC-reported price per share
- $79.33
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares is tracked under CUSIP 10919W405.
- 100 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 94 to 100 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $670,275,618 to $653,781,549.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 100 institutions filings for Q2 2026.
Security key
10919W405
Latest holder period
Q2 2026
13F holders
100
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
DRUG full holder history
BRIGHT MINDS BIOSCIENCES INC. SEC filings
BRIGHT MINDS BIOSCIENCES INC. company facts
BRIGHT MINDS BIOSCIENCES INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 10919W405:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
DRUG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| McDonald Ian | 14% | $85,992,664 | 1,396,665 | Ian McDonald | 04 Nov 2024 | |||
| JANUS HENDERSON GROUP PLC | 13% | -12% | $107,305,270 | +$10,721,888 | 1,284,324 | +11% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| Cormorant Asset Management, LP | 9.2% | -5.4% | $70,056,000 | -$3,892,000 | 900,000 | -5.3% | Cormorant Asset Management, LP | 30 Jun 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 5.2% | -20% | $42,163,090 | +$4,216,017 | 504,645 | +11% | Vivo Opportunity Fund Holdings, L.P. | 31 Mar 2026 |
| Vestal Point Capital, LP | 5% | $41,133,252 | 492,319 | Vestal Point Capital, LP | 31 Mar 2026 | |||
| PERCEPTIVE ADVISORS LLC | 4.6% | -28% | $40,171,019 | +$414,952 | 449,290 | +1% | Perceptive Advisors LLC | 31 Dec 2025 |
| Adage Capital Management, L.P. | 3.4% | -36% | $26,076,400 | -$4,728,235 | 335,000 | -15% | Adage Capital Management, L.P. | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 2.9% | $6,376,530 | 206,427 | RA Capital Management, L.P. | 31 Mar 2025 | |||
| Sio Capital Management, LLC | 2.7% | -65% | $11,571,744 | -$19,506,679 | 190,764 | -63% | Sio Capital Management, LLC | 30 Sep 2025 |
| Point72 Asset Management, L.P. | 3% | $4,175,988 | 135,189 | Point72 Asset Management, L.P. | 31 Dec 2024 | |||
| Commodore Capital LP | 0.3% | -99% | $1,685,468 | -$43,019,532 | 18,851 | -96% | Commodore Capital LP | 31 Dec 2025 |
As of 30 Jun 2026, 100 institutional investors reported holding 9,311,244 shares of BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG). This represents 95% of the company’s total 9,814,613 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
83%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 14% | 1,349,107 | 0% | 0.04% | $94,821,986 |
| Cormorant Asset Management, LP | 9.2% | 900,000 | -15% | 3.3% | $63,180,000 |
| BlackRock, Inc. | 7% | 686,184 | +10% | 0% | $48,170,117 |
| Vivo Capital, LLC | 5.7% | 557,172 | 0% | 3.6% | $39,113,474 |
| Vestal Point Capital, LP | 5.6% | 545,000 | +11% | 0.89% | $38,259,000 |
| BRAIDWELL LP | 4.9% | 483,822 | -10% | 1.3% | $33,964,304 |
| Driehaus Capital Management LLC | 4.4% | 433,377 | +0.2% | 0.18% | $30,423,065 |
| Balyasny Asset Management L.P. | 3.5% | 345,053 | +16% | 0.04% | $24,222,721 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.4% | 335,000 | -32% | 0.03% | $23,517,000 |
| Point72 Asset Management, L.P. | 3.3% | 327,416 | 0.04% | $22,984,603 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.9% | 283,000 | 0% | 0.21% | $19,866,600 |
| RA CAPITAL MANAGEMENT, L.P. | 2.7% | 265,000 | 0% | 0.16% | $18,603,000 |
| Parkman Healthcare Partners LLC | 2.1% | 205,053 | +411% | 1.5% | $14,394,721 |
| MPM BIOIMPACT LLC | 2.1% | 202,114 | -4.7% | 0.87% | $14,188,403 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.7% | 171,315 | +25% | 0% | $12,026,312 |
| GOLDMAN SACHS GROUP INC | 1.4% | 133,689 | +80% | 0% | $9,384,968 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.3% | 130,013 | 0% | 0.12% | $9,126,913 |
| STATE STREET CORP | 1.2% | 122,178 | +13% | 0% | $8,576,896 |
| SEVEN GRAND MANAGERS, LLC | 1.2% | 120,000 | 0% | 0.34% | $8,424,000 |
| GREAT POINT PARTNERS LLC | 1.1% | 109,603 | -50% | 1.8% | $7,694,131 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 104,146 | +17% | 0% | $7,311,049 |
| ORBIMED ADVISORS LLC | 0.95% | 93,000 | +132% | 0.12% | $6,528,600 |
| ACUTA CAPITAL PARTNERS, LLC | 0.94% | 92,745 | -17% | 4.5% | $6,510,699 |
| Ikarian Capital, LLC | 0.91% | 88,951 | -47% | 1% | $6,244,361 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.82% | 80,060 | +32% | 0% | $5,620,212 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Latest
Q2 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 9,311,244 | $653,781,549 | +$2,881,153 | $70.20 | 100 |
| 2026 Q1 | 9,188,601 | $670,275,618 | +$189,182,760 | $72.97 | 94 |
| 2025 Q4 | 6,590,203 | $514,917,301 | +$43,333,109 | $78.04 | 74 |
| 2025 Q3 | 6,040,789 | $366,118,700 | +$48,861,748 | $60.66 | 63 |
| 2025 Q2 | 5,234,387 | $136,973,710 | -$2,453,899 | $26.11 | 46 |
| 2025 Q1 | 5,217,399 | $188,361,504 | +$11,625,261 | $36.07 | 34 |
| 2024 Q4 | 4,897,032 | $176,406,965 | +$167,324,812 | $36.02 | 31 |
| 2024 Q3 | 191,547 | $229,810 | -$6,160 | $1.17 | 6 |
| 2024 Q2 | 197,030 | $207,191 | -$19,280 | $1.05 | 5 |
| 2024 Q1 | 213,375 | $255,563 | -$27,190 | $1.20 | 7 |
| 2023 Q4 | 228,082 | $329,806 | +$48,212 | $1.43 | 7 |
| 2023 Q3 | 194,505 | $309,171 | +$309,171 | $1.60 | 5 |